New FDA rule aims to highlight vaccine safety
The US Food and Drug Administration (FDA) yesterday said it wanted two months of safety data for new COVID-19 vaccines
Updated: Oct 19, 2020
You must be signed in to read this analysis
What is this?
This summary is from the Oxford Analytica Daily Brief, which analyses geopolitical, economic, social, business and industrial developments on a global and regional basis, providing clients with timely, authoritative analysis every business day of the year. Find out more about the Oxford Analytica Daily Brief, or request a trial.
This summary refers to the following article(s).